Related Experiment Videos
Insights
Race significantly impacts kidney transplant outcomes, with differences in graft survival observed across racial groups and primary diseases. HLA tissue types and pre-transplant health also influence success rates.
Area of Science:
- Nephrology
- Immunogenetics
- Transplantation Medicine
Background:
- End-stage renal disease (ESRD) etiology varies significantly across racial groups, including White, Black, Hispanic, and Asian populations.
- Racial disparities exist in the prevalence of diseases leading to ESRD, such as insulin-dependent diabetes mellitus (IDDM), hypertensive nephrosclerosis (NS), and chronic glomerulonephritis (CGN).
- Understanding these demographic and etiological differences is crucial for analyzing kidney transplant outcomes.
Purpose of the Study:
- To investigate the influence of race, primary kidney disease, and human leukocyte antigen (HLA) tissue types on kidney transplant graft survival.
- To identify specific HLA alleles associated with improved graft survival in different disease and racial cohorts.
- To assess the impact of recipient age, sex, and pre-transplantation health status on transplant outcomes.
Main Methods:
- Retrospective analysis of kidney transplant recipient and donor data, focusing on primary ESRD causes, race, HLA typing (specifically HLA-DR), and graft survival rates.
- Statistical comparisons of graft survival rates across different racial groups, primary diseases, and HLA tissue types.
- Evaluation of demographic factors (age, sex) and pre-transplant health status as predictors of transplant success.
Main Results:
- Race was a dominant factor in graft survival differences, more so than the primary disease, particularly among White recipients.
- One-year graft survival varied by primary disease, with IgA nephropathy showing the highest rates and systemic lupus erythematosus (SLE) the lowest.
- Specific HLA-DR types (e.g., HLA-DR3/4 in IDDM, HLA-DR2/3 in SLE, HLA-DR2 in Goodpasture's syndrome) were associated with significantly higher graft survival in certain patient groups and races. HLA-DR1 showed benefit in non-HLA-DR-associated diseases.
- Black recipients under 50 had poorer outcomes than comparable Whites. Pre-transplant health status significantly influenced graft survival across all disease groups.
Conclusions:
- Racial background and specific HLA tissue types are critical determinants of kidney transplant success, necessitating tailored approaches in recipient selection and management.
- The association between certain HLA-DR alleles and improved graft survival highlights the potential for immunogenetic matching to optimize transplant outcomes.
- Addressing racial disparities, recipient health status, and age-related factors is essential for improving long-term kidney allograft function.
Abstract:
1. The most common disease leading to end-stage renal disease were IDDM for Whites (36%), hypertensive NS for Blacks (26%), and CGN for Hispanics (35%) and Asians (47%). These racial differences should be taken into account in analyzing outcomes with respect to disease. 2. Differences in graft survival associated with different primary diseases were more apparent among Whites than Blacks. Race, rather than disease, was the dominant factor. 3. One-year graft survival was consistently highest for patients with IgA nephropathy (87%) and poorest for patients with SLE (78%). The difference across the spectrum of original diseases was significant (p < 0.001). 4. About 84% of White diabetics and 90% of those under age 50 had an HLA-DR3 or 4 tissue type compared with 50% of White donors (p < 0.001). The 1-year graft survival rate was 80% for DR3 or 4 IDDM patients and 74% for non-DR3/4 patients (p < 0.001). Black IDDM patients also had a significantly increased frequency of DR3 and 4 compared with Black donors (46% vs 32%, p < 0.001) and a similar trend toward higher graft survival, although the difference was not significant. 5. Of Whites transplanted with SLE, 60% had HLA-DR2 or 3 compared with 47% of donors (p < 0.001) and those with DR2 or 3 had significantly higher 1-year graft survival rates. Similar trends were noted for Blacks with SLE. 6. HLA-DR2 was present in 46 of 72 patients (64%) transplanted for Goodpasture's syndrome, compared with 28% of donors. Despite the small numbers, 1-year grafts survival was significantly better in the HLA-DR2 group (p = 0.006). 7. Significantly higher graft survival rates were observed among patients with HLA-DR1 in non-HLA-DR-associated diseases (CGN, IN, NS, or PC) but not in HLA-DR-associated diseases such as IDDM and SLE. 8. There were significant differences in recipient age and sex distributions in the major disease groups. Blacks under age 50 had significantly poorer outcomes than comparable Whites. 9. Pretransplantation health status influenced graft outcome in all disease groups. Patients with IDDM or NS were generally less healthy and correspondingly more debilitated than patients with other diseases. 10. Diabetic given a simultaneous kidney-pancreas transplant had 83% 1-year graft survival compared with 78% for those given a kidney alone (p < 0.001).